[GLMD] YoY Annual Result on 31-Dec-2012 [#FY]

Stock
[GLMD] Galmed Pharmaceuticals Ltd.
Announcement Date
30-Dec-2012
Financial Year
2012
Quarter
31-Dec-2012 [#FY]
Profit Trend
YoY-
Quarter Report
GLMD's Result
GLMD's Financial Summary
View:
Show?
Annual Result
31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 CAGR
Revenue 2,038 1,085 467 0 0 0 0 -
PBT -9,781 -12,299 -16,847 -10,622 -9,102 -17,484 -3,143 20.81%
Tax 75 12,364 106 21,244 1 1 6 52.31%
NP -9,856 -12,299 -16,953 -10,622 -9,103 -17,485 -3,149 20.93%
Tax Rate - - - - - - - -
Total Cost 11,894 13,384 17,420 10,622 9,103 17,485 3,149 24.78%
Ratio Analysis
31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 CAGR
NP Margin -483.61 -1,133.55 -3,630.19 0.00 0.00 0.00 0.00 -
Per Share
31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 CAGR
EPS -8.15 -14.77 -22.36 -14.35 -13.23 -24.57 -9.32 -2.20%
EPS Diluted -8.15 -14.77 -22.36 -14.35 -13.23 -24.57 -9.32 -2.20%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.